Prospective Clinical Study of Different Intraocular Lens Implantation Designed for the Correction of Presbyopia
NCT ID: NCT04265846
Last Updated: 2022-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
140 participants
OBSERVATIONAL
2020-05-31
2022-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Clinical Study of Unilateral or Bilateral Implantation of Intraocular Lens in Cataract Patients
NCT04265820
Evaluating Presbyopia-Correcting IOLs in Complex Cataract Cases With Anterior Segment Abnormalities
NCT07321756
Study of Presbyopia-correcting Intraocular Lenses in Eyes With Previous Corneal Refractive Surgery
NCT04522427
Presbyopic Phakic Intraocular Lens for Myopia Correction
NCT03836898
A Comparison of Visual Function After Bilateral Implantation of Presbyopia-Correcting Intraocular Lenses (IOLs)
NCT01257217
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bifocal IOL group
The cataract patients who ask for bilateral phacoemulsification and bifocal IOLs implantation.
bifocal IOL
The patients will undergo bilateral phacoemulsification and bifocal IOLs implantation.
mix bifocal IOL group
The cataract patients who ask for phacoemulsification and mix different bifocal IOLs implantation bilaterally
mix bifocal IOL
The patients will undergo phacoemulsification and mix different bifocal IOLs implantation bilaterally.
trifocal IOL group
The cataract patients who ask for bilateral phacoemulsification and trifocal IOLs implantation.
trifocal IOL
The patients will undergo bilateral phacoemulsification and trifocal IOLs implantation.
EDOF IOL group
The cataract patients who ask for bilateral phacoemulsification and EDOF IOLs implantation.
EDOF IOL
The patients will undergo bilateral phacoemulsification and EDOF IOLs implantation.
blend vision group
The cataract patients who ask for phacoemulsification and different IOLs implantation bilaterally.
different IOLs
The patients will undergo phacoemulsification and different IOLs implantation bilaterally.
monovision designed group
The cataract patients who ask for bilateral phacoemulsification and monofocal IOLs implantation with monovision designed.
monofocal IOL
The patients will undergo bilateral phacoemulsification and monofocal IOLs implantation with monovision designed.
monofocal IOL group
The cataract patients who ask for bilateral phacoemulsification and monofocal IOLs implantation with emmetropia designed.
monofocal IOL
The patients will undergo bilateral phacoemulsification and monofocal IOLs implantation with emmetropia designed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bifocal IOL
The patients will undergo bilateral phacoemulsification and bifocal IOLs implantation.
mix bifocal IOL
The patients will undergo phacoemulsification and mix different bifocal IOLs implantation bilaterally.
trifocal IOL
The patients will undergo bilateral phacoemulsification and trifocal IOLs implantation.
EDOF IOL
The patients will undergo bilateral phacoemulsification and EDOF IOLs implantation.
different IOLs
The patients will undergo phacoemulsification and different IOLs implantation bilaterally.
monofocal IOL
The patients will undergo bilateral phacoemulsification and monofocal IOLs implantation with monovision designed.
monofocal IOL
The patients will undergo bilateral phacoemulsification and monofocal IOLs implantation with emmetropia designed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Regular corneal topography and Preoperative corneal astigmatism ≤ 0.75 Diopter
Exclusion Criteria
* In the presence of other ocular diseases that may affect the stability of the lens capsule (pseudoexfoliation syndrome, glaucoma, traumatic cataract, Marfan syndrome, etc.)
* Pupil abnormality (non-reactive pupil, tonic pupils, abnormally shaped pupils, etc.)
* History of any clinically significant retinal pathology or ocular diagnosis (e.g. diabetic retinopathy, ischemic diseases, macular degeneration, retinal detachment, optic neuropathy optic nerv atrophy, amblyopia, strabismus, microphthalmos, aniridia, epiretinal membrane etc.) in the study eyes that could alter or limit final postoperative visual prognosis.
* Patients with history of ocular trauma or prior ocular surgery including refractive procedures
* postoperative visual acuity of worse than 0.2 logMAR in any eye
* Patients using systemic or ocular medication that affect visual acuity.
* Patients participating in other clinical trials during the study.
50 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
People's Hospital of Guangxi Zhuang Autonomous Region
OTHER
Peking University Third Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Qi Hong, PhD，MD
Role: STUDY_DIRECTOR
Peking University Third Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University Third Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Sun T, Zhao X, Liu Y, Lan Q, Tang C, Qin R, Bian L, Li W, Qi H. Neurosensory binocular vision after bilateral implantation of an extended depth of focus intraocular lens with micro-monovision: a prospective cohort study. BMC Ophthalmol. 2025 May 19;25(1):294. doi: 10.1186/s12886-025-04125-5.
Sun T, Liu Y, Gao Y, Tang C, Lan Q, Yang T, Zhao X, Qi H. Comparison of visual outcomes of a diffractive trifocal intraocular lens and a refractive bifocal intraocular lens in eyes with axial myopia: a prospective cohort study. BMC Ophthalmol. 2022 Oct 20;22(1):407. doi: 10.1186/s12886-022-02626-1.
Lan Q, Liu Y, Xu F, Li M, Li Y, Yang T, Sun T, Yao G, Ma B, Tao L, Xiao X, Feng XL, Zeng S, Qi H. Cost-Effectiveness of Presbyopia Correction Among Seven Strategies of Bilateral Cataract Surgery Based on a Prospective Single-Blind Two-Center Trial in China. Ophthalmol Ther. 2022 Dec;11(6):2067-2082. doi: 10.1007/s40123-022-00562-3. Epub 2022 Sep 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20191129
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.